View drug registration information details.
Items | Registration information |
ID | 1531 |
No | 1531 |
Brand Name | REVENTA TABLETS 10 MG |
Ingredients | ALENDRONATE SODIUM USP EQ.TO ALENDRONIC ACID 10 MG |
Dosage Form | TABLET |
Primary Packaging | BLISTERPACK |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | 1 BLISTER X 10 TABLETS/BOX |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | IS INDICATED: IN POSTMENOPAUSAL WOMEN FOR THE TREATMENT OF OSTEOPOROSIS TO PREVENT FRACTURES, INCLUDING THOSE OF THE HIP AND SPINE, IN POSTMENOPAUSAL WOMEN WHO ARE AT RISK OF DEVELOPING OSTEOPOROSIS, FOR THE TREATMENT OF OSTEOPOROSIS IN MEN TO PREVENT FRACTURES… |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | BEIGE COLORED, SQUARE TABLETS, MARKED BISECT LINE ON ONE SIDE AND OTHER SIDE IS PLAIN |
Note | |
License Owner | LAO INTER PHARMA CO.,LTD |
Manufacturer | GETZ PHARMA (PRIVATE) LIMITED |
Country | PAKISTAN |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 06 I 3108/08 |
FDD Registration Date | 10-Feb-2023 |
Expiry Date | 09-Feb-2026 |
Back to drug list
|